차살리실산 비스무트 시장 보고서(2025년)
Bismuth Subsalicylate Global Market Report 2025
상품코드 : 1760487
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,510,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,409,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,309,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

차살리실산 비스무트 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.9%의 CAGR로 23억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 성장 전망은 위장 장애 유병률 증가, 일반의약품(OTC) 수요 증가, 소화기 건강에 대한 인식 증가, 제약 산업 확대, 신흥 시장에서의 헬스케어 인프라 개발 등의 요인에 의해 이루어질 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 제산제 및 메스꺼움 방지제의 인기, 액상 및 정제 형태의 차살리실산 비스무트의 가용성, 환자 순응도를 향상시키는 제제의 발전, 제약사 간의 전략적 제휴, 차살리실산 비스무트 기반 브랜드 제제 개발 등이 있습니다.

위장 장애의 유병률 증가는 향후 몇 년 동안 차살리실산 비스무트 시장의 성장을 촉진할 것으로 예상됩니다. 위장 장애는 위, 장 및 관련 기관을 포함한 소화관에 영향을 미치며, 종종 통증, 복부 팽만감, 배변의 변화와 같은 증상을 유발합니다. 가공식품의 과다 섭취, 식이섬유 섭취 부족 등 식습관 장애는 장내 세균총의 균형을 깨뜨리고 소화를 방해하여 위장 장애를 증가시키는 주요 원인으로 작용합니다. 차살리실산 비스무트는 장내 염증을 억제하고 유해한 박테리아의 증식을 억제하여 설사와 같은 위장 장애를 완화하는 데 일반적으로 사용됩니다. 예를 들어, ScienceDirect가 2025년 5월에 발표한 보고서에 따르면, 2022년에는 약 2,350만 건의 위장 내시경 검사가 실시되어 전년 대비 6% 증가하였다고 합니다. 그 결과, 소화기 질환의 유병률 증가가 차살리실산 비스무트의 수요를 견인할 것으로 예상됩니다.

제약 산업의 성장은 차살리실산 비스무트 시장 확대를 촉진할 것으로 예상됩니다. 제약 산업은 건강 증진 및 다양한 질병을 치료하기 위한 의약품 및 치료 제품의 연구 개발, 제조 및 마케팅에 주력하고 있습니다. 만성질환이 전 세계적으로 확산됨에 따라 혁신적인 치료법에 대한 수요는 계속 증가하고 있으며, 이는 제약 분야의 성장을 촉진하고 있습니다. 이러한 확장은 차살리실산 비스무트의 고급 제형과 유통 채널의 확대로 위장 장애 치료제로서 전 세계적으로 쉽게 이용할 수 있도록 하고 있습니다. 예를 들어, 국제제약협회(IFPMA)가 2024년 11월에 보고한 바에 따르면, 제약산업은 2022년 세계 GDP에 2조 2,950억 달러의 기여를 할 것이며, 그 중 직접 기여분은 7,550억 달러로 세계 GDP의 0.7%에 해당합니다. 제약 산업의 지속적인 성장은 차살리실산 비스무트의 개발 및 유통을 지원할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Bismuth subsalicylate is an over-the-counter medication that alleviates digestive symptoms by coating the stomach lining to protect it from acid, reducing inflammation, and exhibiting mild antibacterial properties. It helps fight bacteria and soothe irritation, while the subsalicylate (a compound related to aspirin) aids in reducing inflammation and intestinal discomfort.

The main forms of bismuth subsalicylate include bismuth subsalicylate tablets, bismuth subsalicylate suspension, and bismuth subsalicylate chewable tablets. Bismuth subsalicylate tablets are solid, swallowable tablets containing a specific amount of the compound. It is distributed through various channels such as online pharmacies, retail pharmacies, supermarkets, hypermarkets, and health and wellness stores. This medication is used for gastrointestinal disorders, diarrhea, nausea, heartburn, and indigestion. It is used by a variety of end-users, including adult consumers, pediatric consumers, healthcare professionals, caretakers, and guardians.

The bismuth subsalicylate market research report is one of a series of new reports from The Business Research Company that provides bismuth subsalicylate market statistics, including bismuth subsalicylate industry global market size, regional shares, competitors with a bismuth subsalicylate market share, detailed bismuth subsalicylate market segments, market trends and opportunities, and any further data you may need to thrive in the bismuth subsalicylate industry. This bismuth subsalicylate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bismuth subsalicylate market size has grown strongly in recent years. It will grow from $1.70 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period can be attributed to factors such as the rising geriatric population, increased disposable income, growing consumer preference for self-medication, a surge in travel-related gastrointestinal issues, and the increased consumption of processed foods contributing to digestive problems.

The bismuth subsalicylate market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The projected growth during the forecast period is driven by factors including the increasing prevalence of gastrointestinal disorders, rising demand for over-the-counter (OTC) medications, growing awareness of digestive health, the expansion of the pharmaceutical industry, and the development of healthcare infrastructure in emerging markets. Key trends in the forecast period include the popularity of antacid and anti-nausea medications, the availability of bismuth subsalicylate in both liquid and tablet forms, advancements in drug formulations that improve patient compliance, strategic collaborations between pharmaceutical companies, and the development of bismuth subsalicylate-based branded formulations.

The rising prevalence of gastrointestinal disorders is expected to drive the growth of the bismuth subsalicylate market in the coming years. Gastrointestinal disorders affect the digestive tract, including the stomach, intestines, and related organs, and often result in symptoms such as pain, bloating, and changes in bowel movements. Poor dietary habits, such as excessive consumption of processed foods and insufficient fiber intake, are major contributors to the increase in gastrointestinal disorders, as they disrupt the balance of gut microbiota and impair digestion. Bismuth subsalicylate is commonly used to alleviate gastrointestinal issues such as diarrhea by reducing gut inflammation and inhibiting the growth of harmful bacteria. For instance, a report published by ScienceDirect in May 2025 stated that approximately 23.5 million gastrointestinal endoscopies were performed in 2022, marking a 6% increase from the previous year. Consequently, the growing prevalence of gastrointestinal disorders will drive the demand for bismuth subsalicylate.

The growth of the pharmaceutical industry is expected to fuel the expansion of the bismuth subsalicylate market. The pharmaceutical industry focuses on the research, development, manufacturing, and marketing of medications and therapeutic products to improve health and treat various medical conditions. As chronic diseases become more prevalent globally, the demand for innovative treatments continues to rise, prompting further growth in the pharmaceutical sector. This expansion is enhancing the availability of advanced formulations and distribution channels for bismuth subsalicylate, making it more accessible worldwide as a treatment for gastrointestinal disorders. For example, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reported in November 2024 that the pharmaceutical industry contributed $2,295 billion to the global GDP in 2022, with $755 billion from direct contributions, representing 0.7% of global GDP. The continued growth of the pharmaceutical industry is expected to support the development and distribution of bismuth subsalicylate.

Major companies in the bismuth subsalicylate market are innovating new formulations, such as chewable tablets, to improve medication adherence and provide more effective digestive relief. Chewable tablets are designed to be easier to consume and allow for faster absorption compared to traditional tablets. For example, in May 2025, Wonderbelly, a U.S.-based pharmaceutical company, introduced a dye-free alternative to Pepto-Bismol, offering chewable tablets that provide relief from upset stomach, diarrhea, indigestion, and nausea. These tablets contain the same active ingredient-bismuth subsalicylate-but are formulated without dyes or talc, offering a more consumer-friendly option.

Major players in the bismuth subsalicylate market are Procter & Gamble, GlaxoSmithKline Plc, Perrigo Company Plc, Siegfried AG, Laboratorios Imperiales S.A. de C.V., Shandong Xinhua Pharmaceutical Co. Ltd., Alpha Chemika, JQC (Huayin) Pharmaceutical Co. Ltd., Chr. Olesen Group, Vital Materials Co. Ltd., Shanpar Industries Pvt. Ltd., OCB Pharmaceutical, Muby Chemicals, A. B. Enterprises, Samuh Laxmi, Lumax Pharmaceutical Labs Pvt. Ltd., GB Nitrochem Pvt. Ltd., Indian Platinum Private Limited, Organs Bio Lab Private Limited, Maan Medex Private Limited.

North America was the largest region in the bismuth subsalicylate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bismuth subsalicylate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bismuth subsalicylate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bismuth subsalicylate market consists of sales of stomach relief caplets, travel sickness relief kits, digestive aid strips, and stomach pain relief lozenges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bismuth Subsalicylate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bismuth subsalicylate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bismuth subsalicylate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bismuth subsalicylate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bismuth Subsalicylate Market Characteristics

3. Bismuth Subsalicylate Market Trends And Strategies

4. Bismuth Subsalicylate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bismuth Subsalicylate Growth Analysis And Strategic Analysis Framework

6. Bismuth Subsalicylate Market Segmentation

7. Bismuth Subsalicylate Market Regional And Country Analysis

8. Asia-Pacific Bismuth Subsalicylate Market

9. China Bismuth Subsalicylate Market

10. India Bismuth Subsalicylate Market

11. Japan Bismuth Subsalicylate Market

12. Australia Bismuth Subsalicylate Market

13. Indonesia Bismuth Subsalicylate Market

14. South Korea Bismuth Subsalicylate Market

15. Western Europe Bismuth Subsalicylate Market

16. UK Bismuth Subsalicylate Market

17. Germany Bismuth Subsalicylate Market

18. France Bismuth Subsalicylate Market

19. Italy Bismuth Subsalicylate Market

20. Spain Bismuth Subsalicylate Market

21. Eastern Europe Bismuth Subsalicylate Market

22. Russia Bismuth Subsalicylate Market

23. North America Bismuth Subsalicylate Market

24. USA Bismuth Subsalicylate Market

25. Canada Bismuth Subsalicylate Market

26. South America Bismuth Subsalicylate Market

27. Brazil Bismuth Subsalicylate Market

28. Middle East Bismuth Subsalicylate Market

29. Africa Bismuth Subsalicylate Market

30. Bismuth Subsalicylate Market Competitive Landscape And Company Profiles

31. Bismuth Subsalicylate Market Other Major And Innovative Companies

32. Global Bismuth Subsalicylate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bismuth Subsalicylate Market

34. Recent Developments In The Bismuth Subsalicylate Market

35. Bismuth Subsalicylate Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기